Case Report: Transformation From Non-Small Cell Lung Cancer to Small Cell Lung Cancer During Anti-PD-1 Therapy: A Report of Two Cases.

Frontiers in Oncology
Qian ShenJianying Zhou

Abstract

Histological transformation of lung cancer to small cell lung cancer (SCLC) is uncommon. It is a small subset of the possible resistance mechanisms, even in epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitors. Reports on programmed cell death-1 (PD-1) inhibitors are rare. We report two cases of lung squamous carcinomas that transformed to SCLC during anti-PD-1 therapy, and present a detailed description of histological examination of the pre-and post-transformation tissues, hitherto absent from reports on the topic. Case 1: A 69-year-old man was diagnosed with stage IVa squamous cell carcinoma of the lung. He had a programmed cell death-ligand 1 tumor proportion score ≥50%. He achieved partial response after four cycles of sintilimab as first-line treatment. However, sintilimab was discontinued because of severe decrease in hemoglobin levels and platelet counts. Moreover, the occurrence of pleural effusion favored disease progression. Interestingly, bone marrow puncture and biopsy showed transformation to SCLC. Case 2: A 71-year-old man diagnosed with stage IIIa lung squamous cell carcinoma received neoadjuvant chemotherapy, underwent radical surgery, and final...Continue Reading

References

Jan 25, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Emma NorkowskiVincent Thomas de Montpréville
Jan 26, 2016·CA: a Cancer Journal for Clinicians·Wanqing ChenJie He
May 11, 2016·Journal of Pathology and Translational Medicine·Soomin AhnWoong-Yang Park
Oct 11, 2016·The New England Journal of Medicine·Martin ReckUNKNOWN KEYNOTE-024 Investigators
Apr 11, 2017·Respiratory Medicine Case Reports·Takuma ImakitaTadashi Mio
May 13, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·June-Koo LeeYoung Seok Ju
May 24, 2017·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Chia-Lin HsuYih-Leong Chang
Jul 12, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anna F FaragoLecia V Sequist
Nov 14, 2017·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Martin ReckRichard J Gralla
Oct 14, 2018·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Neal ReadyScott J Antonia
Dec 2, 2018·Lung Cancer : Targets and Therapy·Nadine AbdallahAmmar Sukari
Dec 14, 2018·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Wade T IamsChristine M Lovly
Jan 9, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martin ReckJulie R Brahmer
Jun 23, 2019·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Michael OffinHelena A Yu
Nov 5, 2019·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Jair BarAmir Onn
Jan 9, 2020·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Jul 1, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P E PostmusUNKNOWN ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.